Shows
Niere2goMein erstes Paper im New England Journal of MedicineEin Gespräch mit Dr. Katharina Mayer und Dr. Felicitas Hengel während der Jahrestagung der Deutschen Gesellschaft für Nephrologie 2024 in Berlin.
Die beiden Ärztinnen konnten als Erstautor:innen im Mai erfolgreich und zeitgleich eine Arbeit im New England Journal of Medicine veröffentlichen. Daniela und Bernd sprechen mit den beiden Assistenzärztinnen darüber, wie ihnen dies gelungen ist, welche Emotionen und Arbeit sich hinter so einem herausragenden Resultat verbergen und welche Gedanken sich Katharina Mayer und Felicitas Hengel über die nähere Zukunft machen.
2024-10-0138 min
GN in TenBoard Review Bonus #2: Minimal Change DiseaseIn this special bonus episode of the podcast, Koyal and Kenar provide a maximally useful review of minimal change disease, from diagnosis (including secondary causes to screen for) to treatment options, including how to decide which patients may do better with which therapies. Can’t get enough minimal change? Check out Episode 6 (with Astrid Weins) and Episode 7 (with Felicitas Hengel and Nicola Tomas) for more on the potential role of anti-nephrin autoantibodies in MCD.ReferencesKDIGO guidelines: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GD-Guideline-Key-Takeaways-for-Clinicians-Minimal-Change-Disease.pdfAnt...
2024-09-1624 minGN in TenEpisode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin AutoantibodiesIn this episode, we talk with Dr. Felicitas Hengel, MD and Dr. Nicola Tomas, MD (both at the University Medical Center Hamburg-Eppendorf) about their groundbreaking anti-nephrin autoantibody research that was just presented at the 2024 ERA Congress and published in the New England Journal of Medicine. Is this a game-changer for minimal change? How could this new understanding change diagnosis and treatment in the future? Are anti-nephrin autoantibodies the next PLA2R? What are the next steps for follow-up studies? And how do you do a big international study like this, anyway? References:The s...
2024-06-0616 min